Global Bilirubin Blood Test Market Research Report  –Forecast till 2027

Global Bilirubin Blood Test Market Research Report –Forecast till 2027

ID: MRFR/HC/0249-CRR | November, 2017 | Region: Global | 90 pages | Cooked Research Reports

Global Bilirubin Blood Test Market Research Report, Test Type (Indirect, Direct, Total Serum Bilirubin) Product Type (Analyzers, Bilirubinometer) Application (Pediatric/Infants, Adults) End Users (Hospitals, Home Healthcare) - Global Forecast till 2027 


Market Scenario:
Bilirubin is a yellow pigment that is present in an individual's blood and stool.  It is produced in the body when hemoglobin in old red platelets is broken down. The presence of bilirubin is an indication of jaundice. Jaundice is often recognized by the yellowish shade of the skin, tissues, eyes, and certain body liquids. Bilirubin blood test is the process of measuring the amount of bilirubin in a blood sample.  High prevalence of neonatal jaundice in infants and increasing per capita healthcare expenditure drive the market growth. According to the Centres for Disease Control and Prevention in 2015, approximately 60% of full-term infants develop jaundice within several days of birth. Moreover, the Centres for Disease Control and Prevention reported in 2015, in the U.S., the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP) i.e. USD 3.2 trillion. Additionally, increasing demand for portable/hand-held diagnostic devices fuels the market growth. The advantages of portable devices include the elimination of the time-consuming draws. Moreover, such devices are chargeable and come with digital technology, which ensures ease of use and accurate measurement of the results. Following the same trend, Koninklijke Philips N.V. came up with its bilichek system that is a non-invasive bilirubin measurement device. However, lack of awareness and trained professionals is likely to restrain the market growth during the forecast period.
The global bilirubin blood test market is expected to grow at a CAGR of 5.44% during the forecast period.


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 


Figure 1:- Global bilirubin blood test market share, by region

Bilirubin Blood Test Market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Segmentation
The global bilirubin blood test market is segmented on the basis of test type, product type, application, and end users.


On the basis of the test type, the market is segmented into indirect/unconjugated bilirubin test, direct/conjugated bilirubin test, and total serum bilirubin (TSB).


On the basis of the product type, the market is categorized into analyzers, bilirubinometer, and consumable. The analyzers segment is sub-segmented into the photometric analyzer, blood gas analyzer. The bilirubinometer segment is sub-segmented into hand-held, and bench top.


On the basis of application, the market is segmented into pediatric/Infants and adults.


On the basis of end users, the market is segmented into hospitals, pediatric clinics, and home healthcare. 


Regional Analysis
North America dominates the bilirubin blood test market owing to a well-developed healthcare sector. Moreover, the high prevalence of neonatal jaundice in infants and developed economies like the U.S. and Canada, which have high per capita healthcare expenditures fuel the market growth within the region. Additionally, Beckman Coulter, Inc., and Thermo Fisher Scientific Inc. are some of the major players of the global bilirubin blood test market whose presence is marked within the regional boundaries of the North America, fuelling the market growth. 


Europe is the second largest bilirubin blood test market, which is followed by Asia Pacific. Availability of funds for research, well-developed healthcare infrastructure, huge patient population, and government support for research & development drive the market in Europe. Moreover, the presence of developed economies within the region like the U.K and the Germany, which have high healthcare expenditures fuels the market growth. 


Asia Pacific is the fastest growing market due to the presence of developing economies like India and China within the region, which has increasing healthcare expenditures. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is estimated as one of the fastest growing industries and is expected to advance at a CAGR of 22.87% during 2015-20, thereby, will reach USD 280 billion by 2020. This along with favorable government policies is likely to boost the market growth in the presence of a huge opportunity for the untapped market within the region.


Research Methodology


Global bilirubin blood test market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Key players in global bilirubin blood test market
Koninklijke Philips N.V. (Europe), Beckman Coulter, Inc. (Danaher) (U.S.), Thermo Fisher Scientific Inc. (U.S.), Randox Laboratories Ltd. (Europe), and F. Hoffmann-La Roche AG (Europe)

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
2.6 Market Segmentation
2.6.1 By Test Type
2.6.1.1 Introduction
2.6.1.2 Indirect/Unconjugated Bilirubin Test
2.6.1.3 Direct/Conjugated Bilirubin Test
2.6.1.4 Total Serum Bilirubin (TSB)
2.6.2 By Product Type
2.6.2.1 Introduction
2.6.2.2 Consumable
2.6.2.3 Instruments
2.6.2.3.1 Analyzers
2.6.2.3.1.1 Photometric analyzer
2.6.2.3.1.2 Blood gas analyzer
2.6.2.3.2 Bilirubinometer
2.6.2.3.2.1 Hand-held
2.6.2.3.2.2 Bench Top
2.6.3 By Application
2.6.3.1 Introduction
2.6.3.2 Pediatric/Infants
2.6.3.3 Adults
2.6.4 By End User
2.6.4.1 Introduction
2.6.4.2 Hospitals
2.6.4.3 Pediatric clinics
2.6.4.4 Home Healthcare

3.1 Primary Research
3.2 Secondary Research

4.1 Introduction
4.2 Drivers
4.2.1 High Prevalence of Neonatal Jaundice in Infants
4.2.2 Increasing Demand for Portable/Hand-Held Diagnostic Devices
4.3 Restrains
4.3.1 Testing Performed by Non-laboratory Personnel
4.4 Opportunity
4.4.1 Developing Countries Can Become Potential Market for Advanced Bilirubin Blood Test devices
4.5 Challenges
4.5.1 Risk of Errors

5.1 Bilirubin Blood Test Market, By Test Type
5.2 Total Serum Bilirubin (TSB)
5.3 Direct/Conjugated Bilirubin Test
5.4 Indirect/Unconjugated Bilirubin Test

6.1 Bilirubin Blood Test Market, By Product Type
6.2 Consumables
6.3 Instruments
6.3.1 Analyzers
6.3.1.1 Photometric Analyzer
6.3.1.2 Blood Gas Analyzers
6.3.2 Bilirubinometer
6.3.2.1 Bench-top
6.3.2.2 Hand-held

7.1 Bilirubin Blood Test Market, By Application
7.2 Pediatric/Infants
7.3 Adults

8.1 Bilirubin Blood Test Market, By End User
8.2 Hospital
8.3 Pediatric Clinics
8.4 Home Healthcare

9.1 Bilirubin Market By Region
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 South Korea
9.4.5 Rest of APAC
9.5 Rest of the World

10.1 Introduction

11.1 Koninklijke Philips N.V.
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financials
11.1.4 Key Developments
11.2 Beckman Coulter, Inc. (Danaher)
11.2.1 Company Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financials
11.2.4 Key Developments
11.3 Thermo Fisher Scientific Inc.
11.3.1 Company Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financials
11.3.4 Key Developments
11.4 Randox Laboratories Ltd.
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financials
11.4.4 Key developments
11.5 F. Hoffmann-La Roche AG
11.5.1 Company Overview
11.5.2 Product/Business Segment Overview
11.5.3 Financials
11.5.4 Key Developments
11.6 Drägerwerk AG & Co. KGaA
11.6.1 Overview
11.6.2 Product Portfolio
11.6.3 Financials
11.6.4 Key Developments
11.7 Ginevri
11.7.1 Overview
11.7.2 Product Portfolio
11.7.3 Financials
11.8 Advanced Instruments
11.8.1 Overview
11.8.2 Product Portfolio
11.8.3 Financials
11.8.4 Key Developments
11.9 Reichert, Inc.
11.9.1 Overview
11.9.2 Product Portfolio
11.9.3 Financials
11.10 Instrumentation Laboratory
11.10.1 Overview
11.10.2 Product Portfolio
11.10.3 Financials
11.10.4 Key Developments

TABLE 1 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY TEST TYPE, 2013-2027 ($MILLION)
TABLE 2 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY REGION, 2013-2027 ($MILLION)
TABLE 3 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 4 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 5 APAC: BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 6 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED BILIRUBIN TEST, BY REGION, 2013-2027 ($MILLION)
TABLE 7 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 8 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED BILIRUBIN TEST, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 9 APAC: BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED BILIRUBIN TEST, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 10 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY REGION, 2013-2027 ($MILLION)
TABLE 11 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 12 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 13 APAC: BILIRUBIN BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 14 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 15 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY REGION, 2013-2027 ($MILLION)
TABLE 16 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 17 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 18 APAC: BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 19 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS, BY REGION, 2013-2027 ($MILLION)
TABLE 20 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 21 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 22 APAC: BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 23 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY REGION, 2013-2027 ($MILLION)
TABLE 24 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 25 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 26 APAC: BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 27 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY REGION, 2013-2027 ($MILLION)
TABLE 28 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 29 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 30 APAC: BILIRUBIN BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 31 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY REGION, 2013-2027 ($MILLION)
TABLE 32 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 33 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 34 APAC: BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 35 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY REGION, 2013-2027 ($MILLION)
TABLE 36 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 37 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 38 APAC: BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 39 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR BENCH-TOP, BY REGION, 2013-2027 ($MILLION)
TABLE 40 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 41 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR BENCH-TOP, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 42 APAC: BILIRUBIN BLOOD TEST MARKET FOR BENCH-TOP, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 43 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD, BY REGION, 2013-2027 ($MILLION)
TABLE 44 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 45 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 46 APAC: BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 47 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 48 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS, BY REGION, 2013-2027 ($MILLION)
TABLE 49 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 50 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 51 APAC: BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 52 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR ADULTS, BY REGION, 2013-2027 ($MILLION)
TABLE 53 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 54 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR ADULTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 55 APAC: BILIRUBIN BLOOD TEST MARKET FOR ADULTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 56 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
TABLE 57 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY REGION, 2013-2027 ($MILLION)
TABLE 58 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 59 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 60 APAC: BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 61 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY REGION, 2013-2027 ($MILLION)
TABLE 62 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 63 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 64 APAC: BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 65 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE, BY REGION, 2013-2027 ($MILLION)
TABLE 66 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 67 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 68 APAC: BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 69 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY REGION, 2013-2027 ($MILLION)
TABLE 70 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 71 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 72 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 73 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 74 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 75 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 76 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
TABLE 77 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 78 US: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 79 US: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 80 US: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 81 US: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 82 US: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 83 US: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
TABLE 84 US: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 85 CANADA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 86 CANADA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 87 CANADA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 88 CANADA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 89 CANADA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 90 CANADA: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
TABLE 91 CANADA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 92 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 93 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 94 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 95 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 96 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 97 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 98 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY END EUROPEER, 2013-2027 ($MILLION)
TABLE 99 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 100 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 101 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 102 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 103 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 104 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 105 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY END GERMANY, 2013-2027 ($MILLION)
TABLE 106 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 107 UK: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 108 UK: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 109 UK: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 110 UK: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 111 UK: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 112 UK: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 113 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 114 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 115 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 116 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 117 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 118 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2013-2027 ($MILLION)
TABLE 119 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 120 ITALY: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 121 ITALY: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 122 ITALY: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 123 ITALY: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 124 ITALY: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 125 ITALY: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
TABLE 126 ITALY: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 127 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 128 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 129 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 130 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 131 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 132 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2013-2027 ($MILLION)
TABLE 133 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 134 ROE: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 135 ROE: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 136 ROE: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 137 ROE: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 138 ROE: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
TABLE 139 ROE: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 140 ASIA PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2013-2027 ($MILLION)
TABLE 141 ASIA PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 142 ASIA PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 143 ASIA PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 144 ASIA PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 145 ASIA PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY END ASIA PACIFICER, 2013-2027 ($MILLION)
TABLE 146 ASIA PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 147 CHINA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 148 CHINA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 149 CHINA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 150 CHINA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 151 CHINA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 152 CHINA: BILIRUBIN BLOOD TEST MARKET, BY END CHINAER, 2013-2027 ($MILLION)
TABLE 153 CHINA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 154 INDIA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 155 INDIA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 156 INDIA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 157 INDIA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 158 INDIA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 159 INDIA: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2013-2027 ($MILLION)
TABLE 160 INDIA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 161 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 162 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 163 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 164 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 165 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 166 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2013-2027 ($MILLION)
TABLE 167 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 168 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 169 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 170 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 171 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 172 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 173 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY END SOUTH KOREAER, 2013-2027 ($MILLION)
TABLE 174 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 175 ROAPAC: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 176 ROAPAC: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 177 ROAPAC: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 178 ROAPAC: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 179 ROAPAC: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 180 ROAPAC: BILIRUBIN BLOOD TEST MARKET, BY END ROAPACER, 2013-2027 ($MILLION)
TABLE 181 ROAPAC: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 182 ROW: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
TABLE 183 ROW: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2013-2027 ($MILLION)
TABLE 184 ROW: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2013-2027 ($MILLION)
TABLE 185 ROW: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2013-2027 ($MILLION)
TABLE 186 ROW: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
TABLE 187 ROW: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
TABLE 188 ROW: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2013-2027 ($MILLION)
TABLE 189 KEY DEVELOPMENTS OF MAJOR MARKET PLAYERS
TABLE 190 KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENTS
TABLE 191 BECKMAN COULTER, INC.: KEY DEVELOPMENTS
TABLE 192 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS
TABLE 193 F. HOFFMANN-LA ROCHE AG.: KEY DEVELOPMENTS
TABLE 194 DRÄGERWERK AG & CO. KGAA: KEY DEVELOPMENTS
TABLE 195 ADVANCED INSTRUMENTS: KEY DEVELOPMENTS
TABLE 196 INSTRUMENTATION LABORATORY: KEY DEVELOPMENTS

FIGURE 1 GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY TEST TYPE 2015 (%)
FIGURE 2 GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY PRODUCT TYPE, 2015 (%)
FIGURE 3 GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY APPLICATIONS, 2015 (%)
FIGURE 4 GLOBAL BILIRUBIN MARKET SHARE, BY REGION 2015 (%)
FIGURE 5 GLOBAL BILIRUBIN MARKET, BY REGION, 2016-2027 (CAGR%)
FIGURE 6 MARKET STRUCTURE OF GLOBAL BILIRUBIN BLOOD TEST MARKET
FIGURE 7 RESEARCH PROCESS
FIGURE 8 DROC OF GLOBAL BILIRUBIN BLOOD TEST MARKET
FIGURE 9 GROWTH DRIVERS: IMPACT ANALYSIS
FIGURE 10 RESTRAINTS: IMPACT ANALYSIS
FIGURE 11 BILIRUBIN BLOOD TEST MARKET, BY TEST TYPE, 2013-2027 ($MILLION)
FIGURE 12 BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2013-2027 ($MILLION)
FIGURE 13 BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2013-2027 ($MILLION)
FIGURE 14 BILIRUBIN BLOOD TEST MARKET, BY END USER, 2013-2027 ($MILLION)
FIGURE 15 MARKET SHARE ANALYSIS BY KEY PLAYERS 2015 (%)
FIGURE 16 MARKET COMPETITIVE ANALYSIS BY KEY PLAYERS 2015 (%)
FIGURE 17 KONINKLIJKE PHILIPS N.V.: RECENT FINANCIALS
FIGURE 18 KONINKLIJKE PHILIPS N.V.: BUSINESS REVENUE
FIGURE 19 BECKMAN COULTER, INC.: RECENT FINANCIALS
FIGURE 20 BECKMAN COULTER, INC.: BUSINESS REVENUE
FIGURE 21 BECKMAN COULTER, INC.: GEOGRAPHICAL REVENUE
FIGURE 22 THERMO FISHER SCIENTIFIC INC.: RECENT FINANCIALS
FIGURE 23 THERMO FISHER SCIENTIFIC INC.: BUSINESS REVENUE
FIGURE 24 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL REVENUE
FIGURE 25 F. HOFFMANN-LA ROCHE AG.: RECENT FINANCIALS
FIGURE 26 F. HOFFMANN-LA ROCHE AG.: BUSINESS REVENUE
FIGURE 27 F. HOFFMANN-LA ROCHE AG.: GEOGRAPHICAL REVENUE
FIGURE 28 DRÄGERWERK AG & CO. KGAA: RECENT FINANCIALS
FIGURE 29 DRÄGERWERK AG & CO. KGAA: GEOGRAPHICAL REVENUE